期刊文献+

老年冠心病合并糖尿病患者氯吡格雷抵抗的危险因素分析 被引量:5

Risk factors of clopidogrel resistance in elderly patients with coronary heart disease complicating diabetes
下载PDF
导出
摘要 目的 分析老年冠心病合并糖尿病患者氯吡格雷抵抗的危险因素。方法 选取咸阳市中心医院心内科自2008年6月~2014年1月收治入院的接受氯吡格雷治疗的合并糖尿病的老年冠心病患者89例,男性48例,女性41例。根据血栓弹力图检测,抑制率〉50%者为对照组(n=44),抑制率〈50%者为观察组(n=45),比较两组空腹血糖(FPG)、糖化血红蛋白(Hb A1c)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、心肌肌钙蛋白I(c TNI),超敏C反应蛋白(hs-CRP),分析氯吡格雷抵抗的危险因素。结果 观察组在吸烟比例、LDL-C、FPG、Hb A1c、hs-CRP,c Tn I等方面均高于对照组,差异具有统计学意义(P均〈0.05)。结果显示患者FPG(OR=1.879,95%CI:0.954~2.145)、Hb A1c(OR=1.512,95%CI:0.843~1.991)、hsCRP(OR=2.143,95%CI:0.576~2.662)、c Tn I(OR=1.314,95%CI:0.104~3.106)是氯吡格雷抵抗的独立危险因素。观察组术后出现5例心肌梗死,对照组出现1例心肌梗死,两组心肌梗死发生率差异具有统计学意义(P〈0.05)。结论 FPG、Hb A1c、hs-CRP、c Tn I增高是老年冠心病合并糖尿病患者介入治疗术后氯吡格雷抵抗的独立危险因素。 Objective To analyze the risk factors of clopidogrel resistance in elderly patients with coronary heart disease (CHD) complicating diabetes. Methods The patients (n=89, male 48 and female 41) were chosen from Jun. 2008 to Jan. 2014. According to examination of thrombelastogram (TEG), all patients were divided into control group (inhibition rate〉50%, n=44) and observation group (inhibition rate〈50%, n=45). The levels of fasting plasma glucose (FPG), glycated hemoglobin (HbAlc), total cholesterol (TC), triglyceride (TG), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C) and cardiac troponin I (cTnI) were compared between 2 groups, and risk factors of clopidogrel resistance were analyzed. Results The percentage of smoking cases, and levels of LDL-C, FPG, HbA1c, hs-CRP and cTnI were higher in observation group than those in control group (all P〈0.05). FPG (OR=1.879, 95%CI:0.954~2.145), HbA1c (OR=1.512, 95%CI:0.843~1.991), hs-CRP (OR=2.143, 95%CI: 0.576~2.662) and cTnI (OR=1.314, 95%CI: 0.104~3.106) were independent risk factors of clopidogrel resistance. There were 5 cases of myocardial infarction in observation group and 1 in control group (P〈0.05) after interventional therapy. Conclusion The higher levels of FPG, HbA1c, hs-CRP and cTnI are independent risk factors of clopidogrel resistance in elderly patients with CHD complicating diabetes after interventional therapy.
出处 《中国循证心血管医学杂志》 2015年第4期521-523,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 氯吡格雷 糖尿病 冠心病 介入治疗 危险因素 Clopidogrel Diabetes Coronary heart disease Interventional therapy Risk factors
  • 相关文献

参考文献14

  • 1Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)[J]. Lancet,2011,344 (8934):1383-9.
  • 2Angiolillo DJ,Shoemaker SB,Desai B,et al. Randomized Comparison of a High Clopidogrel Maintenance Dose in Patients With Diabetes Mellitus and Coronary Artery Disease Results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) Study[J]. Circulation,2007,115(6):705-16.
  • 3Wilson W,Taubert KA,Gewitz M,et al. Prevention of Infective Endocarditis Guidelines From the American Heart Association: A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group[J]. Circulation,2007,116(15):1736-54.
  • 4钱荣立.关于糖尿病的新诊断标准与分型[J].中国糖尿病杂志,2000,8(1):5-6. 被引量:2314
  • 5Gurbel PA,Tantry US. Clopidogrel resistance?[J]. Thrombosis Research, 2007,120(3):311-21.
  • 6Prabhakaran S,Wells KR,Lee VH,et al. Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting[J]. Am J Neuroradiol,2013,29(2):281-5.
  • 7Michelson AD,Linden MD,Furman MI,et al. Evidence that pre- existent variability in platelet response to ADP accounts for ' clopidogrel resistance ' [J]. J Thromb Haemost,2014,5(1):75-81.
  • 8Go AS,Mozaffarian D,Roger VL,et al. On behalf of the American Heart Association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2013 update: a report from the American Heart Association[J]. Circulation,2013,127(1):e1-e240.
  • 9Go AS,Mozaffarian D,Roger VL,et al. Executive Summary: Heart Disease and Stroke Statistics: 2013 Update: A Report From the American Heart Association[J]. Circulation,2013,127(1):143-6.
  • 10Karathanos A,Geisler T. Monitoring aspirin and clopidogrel response: testing controversies and recommendations[J]. Mol Diagn Ther,2013,17(3): 123-37.

二级参考文献4

共引文献2340

同被引文献54

引证文献5

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部